Phase 2 trial results (48 weeks, adults with obesity): 1 mg dose: 7.2% body weight loss 4 mg dose: 12.9% body weight loss 8 mg dose: 17.3% body weight loss 12 mg dose: 24.2% body weight loss Placebo: 1.6% body weight loss Phase 3 TRIUMPH-4 results: 9 mg dose: 20.0% body weight loss (22.9 kg / 50.5 lbs) 12 mg dose: 23.7% body weight loss (27.2 kg / 60.0 lbs) Placebo: 4.6% body weight loss In a separate phase 3 analysis, retatrutide at the highest dose achieved up to 28.7% weight loss
: :
GHK-Cu (Copper Tripeptide-1) is a natural tripeptide (Gly-His-Lys) combined with a copper ion (Cu)
Endogenous concentrations decline with age, driving research interest in its roles in tissue maintenance, wound repair, and hair follicle biology
Dysbiosis of the gut microbiota disrupts the structure and function of the intestinal epithelial barrier [128], forming harmful metabolic profiles [129], which induce inflammation and immune dysfunction via the gut-kidney axis [130, 131], exacerbating renal injury [132]
In a recent study, cereal fortification, providing 499 and 665 g of folic acid daily, increased plasma folic acid by 64.8% and 105.7%, respectively, and decreased plasma homocysteine by 11% and 14%, respectively (Malinow et al, 1998)
